• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用靶向代谢组学分析鉴定子宫内膜癌的新型诊断生物标志物。

Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.

机构信息

Division of Gynaecology and Perinatology, University Medical Centre Maribor, Maribor, Slovenia; Faculty of Medicine, University of Maribor, Maribor, Slovenia.

Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia; Universal Diagnostics, S.L. Centre of Research Technology and Innovation, University of Seville, Seville, Spain.

出版信息

Adv Med Sci. 2021 Mar;66(1):46-51. doi: 10.1016/j.advms.2020.12.001. Epub 2020 Dec 24.

DOI:10.1016/j.advms.2020.12.001
PMID:33360772
Abstract

PURPOSE

Endometrial cancer (EC) is the most common gynecological malignancy with high disease burden especially in advanced stages of the disease. Our study investigated the metabolomic profile of EC patient's serum with the aim of identifying novel diagnostic biomarkers that could be used especially in early disease detection.

MATERIAL AND METHODS

Using targeted metabolomic serum profiling based on HPLC-TQ/MS, women with EC (n ​= ​15) and controls (n ​= ​21) were examined for 232 endogenous metabolites.

RESULTS

Top performing biomarkers included ceramides, acylcarnitines and 1-methyl adenosine. Top 4 biomarkers combined achieved 94% sensitivity with 75% specificity with AUC 92.5% (CI 90.5-94.5%). Individual markers also provided significant predictive values: C16-ceramide achieved sensitivity 73%, specificity 81%, AUC 0.83, C22-ceramide sensitivity 67%, specificity 81%, AUC 0.77, hydroxyhexadecenoylcarnitine sensitivity 60%, specificity 96%, AUC 0.76 and 1-methyladenosine sensitivity 67%, specificity 81%, AUC 0.75. The individual markers, however, did not reach the high sensitivity and specificity of the 4-biomarker combination.

CONCLUSIONS

Using mass spectrometry targeted metabolomic profiling, ceramides, acylcarnitines and 1-methyladenosine were identified as potential diagnostic biomarkers for EC. Additionally, these identified metabolites may provide additional insight into cancer cell metabolism.

摘要

目的

子宫内膜癌(EC)是最常见的妇科恶性肿瘤,尤其是在疾病晚期,其疾病负担很高。我们的研究旨在通过检测 EC 患者血清的代谢组学特征,寻找新的诊断生物标志物,尤其是在早期疾病检测中。

材料与方法

采用基于 HPLC-TQ/MS 的靶向代谢组学血清分析方法,对 15 例 EC 患者和 21 例对照者进行 232 种内源性代谢物检测。

结果

表现最好的生物标志物包括神经酰胺、酰基肉碱和 1-甲基腺苷。前 4 个标志物联合检测的敏感性为 94%,特异性为 75%,AUC 为 92.5%(90.5-94.5%)。单个标志物也具有显著的预测价值:C16-神经酰胺的敏感性为 73%,特异性为 81%,AUC 为 0.83;C22-神经酰胺的敏感性为 67%,特异性为 81%,AUC 为 0.77;羟基十六烯酰肉碱的敏感性为 60%,特异性为 96%,AUC 为 0.76;1-甲基腺苷的敏感性为 67%,特异性为 81%,AUC 为 0.75。然而,这些单个标志物并未达到 4 个标志物联合检测的高敏感性和特异性。

结论

通过质谱靶向代谢组学分析,发现神经酰胺、酰基肉碱和 1-甲基腺苷可能是 EC 的潜在诊断生物标志物。此外,这些鉴定出的代谢物可能为癌细胞代谢提供更多的见解。

相似文献

1
Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.采用靶向代谢组学分析鉴定子宫内膜癌的新型诊断生物标志物。
Adv Med Sci. 2021 Mar;66(1):46-51. doi: 10.1016/j.advms.2020.12.001. Epub 2020 Dec 24.
2
Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling.基于靶向代谢组学分析鉴定乳腺癌新型诊断生物标志物。
Clin Breast Cancer. 2021 Jun;21(3):e204-e211. doi: 10.1016/j.clbc.2020.09.006. Epub 2020 Nov 11.
3
Metabolomic prediction of endometrial cancer.代谢组学预测子宫内膜癌。
Metabolomics. 2017 Dec 1;14(1):6. doi: 10.1007/s11306-017-1290-z.
4
Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer.代谢组学分析提示长链神经酰胺和神经鞘磷脂可能是上皮性卵巢癌的一种潜在诊断生物标志物。
Clin Chim Acta. 2018 Jun;481:108-114. doi: 10.1016/j.cca.2018.02.029. Epub 2018 Feb 24.
5
Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.包括鞘磷脂和磷脂酰胆碱的血浆水平在内的模型作为子宫内膜癌的诊断和预后生物标志物。
J Steroid Biochem Mol Biol. 2018 Apr;178:312-321. doi: 10.1016/j.jsbmb.2018.01.012. Epub 2018 Jan 31.
6
Metabolomic Signature of Endometrial Cancer.子宫内膜癌的代谢组学特征。
J Proteome Res. 2018 Feb 2;17(2):804-812. doi: 10.1021/acs.jproteome.7b00503. Epub 2018 Jan 2.
7
Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.基于超高效液相色谱-质谱联用的尿液和血清代谢组学分析用于子宫内膜癌的诊断和分类。
Metabolomics. 2024 Jan 28;20(1):18. doi: 10.1007/s11306-023-02085-9.
8
Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.代谢组学鉴定晚期黑色素瘤基于血清的诊断生物标志物。
Metabolomics. 2018 Aug 3;14(8):105. doi: 10.1007/s11306-018-1398-9.
9
Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.精子相关抗原9是子宫内膜癌早期诊断的一个有前景的标志物。
Asian Pac J Cancer Prev. 2013;14(12):7635-8. doi: 10.7314/apjcp.2013.14.12.7635.
10
Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.潜在的血清代谢物和长链非编码 RNA 生物标志物用于子宫内膜癌组织。
J Obstet Gynaecol Res. 2023 Feb;49(2):725-743. doi: 10.1111/jog.15494. Epub 2022 Dec 12.

引用本文的文献

1
Unlocking the Potential of Liquid Biopsy: A Paradigm Shift in Endometrial Cancer Care.释放液体活检的潜力:子宫内膜癌护理的范式转变。
Diagnostics (Basel). 2025 Jul 30;15(15):1916. doi: 10.3390/diagnostics15151916.
2
Serum sphingomyelin levels define oxyhemoglobin desaturation-related metabolic threshold in symptomatic obstructive sleep apnea.血清鞘磷脂水平可界定有症状阻塞性睡眠呼吸暂停中与氧合血红蛋白去饱和相关的代谢阈值。
Sci Rep. 2025 Apr 11;15(1):12533. doi: 10.1038/s41598-025-96386-9.
3
The Interplay between Oxidative Stress and Sphingolipid Metabolism in Endometrial Cancer.
氧化应激与子宫内膜癌中神经酰胺代谢的相互作用。
Int J Mol Sci. 2024 Sep 24;25(19):10243. doi: 10.3390/ijms251910243.
4
Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling.利用血浆代谢组分析鉴定用于子宫内膜癌诊断和治疗反应监测的预测性生物标志物。
Cancer Metab. 2023 Oct 11;11(1):16. doi: 10.1186/s40170-023-00317-z.
5
Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.基于蛋白质组学、代谢组学和临床数据的子宫内膜癌诊断与预后算法:一项系统综述
Front Oncol. 2023 Apr 6;13:1120178. doi: 10.3389/fonc.2023.1120178. eCollection 2023.
6
Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis.用于子宫内膜癌非侵入性诊断的液体生物标志物的诊断准确性:一项系统评价和荟萃分析
Cancers (Basel). 2022 Sep 25;14(19):4666. doi: 10.3390/cancers14194666.
7
Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.多生物样本的多组学分析揭示氨基酸和核苷酸代谢在子宫内膜癌中的作用。
Front Oncol. 2022 Apr 29;12:861142. doi: 10.3389/fonc.2022.861142. eCollection 2022.